> The Cancer Center at Beth Israel Deaconess Medical Center in Boston launched a new Institute for RNA Medicine. Story
> Alnylam Pharmaceuticals ($ALNY) added Amy Schulman to its board of directors. Release
> Ophthalmology company Icon Bioscience completed enrollment of its Phase III trial for an injected, sustained-release formulation of the anti-inflammatory agent dexamethasone following cataract surgery. Release